0WUC47Z
Supplement Mediastinum to No Qualifier with Autologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | W Anatomical Regions, General |
| Operation | U Supplement |
| Body Part | C Mediastinum |
| Approach | 4 Percutaneous Endoscopic |
| Device | 7 Autologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures in this family put in biological or synthetic material - most often surgical mesh - to reinforce or augment a general anatomical region like the abdominal wall or chest wall, without replacing the region's own tissue outright. The classic example is mesh placement during a hernia repair, where the native tissue is preserved but reinforced so it can better withstand pressure and resist recurrence.
This family is used any time the surgical goal is strengthening a structurally weak area rather than fixing a specific tear or restoring damaged anatomy to its prior state. It shows up across abdominal wall reconstructions, chest wall reinforcement after trauma or tumor resection, and similar cases where added material becomes a permanent or long-term part of the repair.
Anatomy & Axis Detail
Mediastinum
The mediastinum is the central thoracic compartment situated between the pleural cavities, containing the heart, great vessels, trachea, esophagus, and thymic remnants along with connective tissue. Supplement procedures in this region are far less common than in peripheral body walls and generally involve reinforcing or patching mediastinal fascia or connective planes after resection of a mass, repair of a vascular sheath defect, or reconstruction following extensive debridement for infection such as mediastinitis. Because the space is densely packed with vital structures, any augmentation material must be biocompatible and unlikely to provoke adhesions that could compromise cardiac or esophageal motion. Coders should confirm the operative report clearly identifies the mediastinum as the site being reinforced rather than a specific organ within it, since procedures on the heart, vessels, or esophagus are captured under those dedicated body systems instead.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Autologous Tissue Substitute
Autologous Tissue Substitute identifies a device value where material harvested from the patient's own body, such as an autograft, is used to replace or reconstruct a body part. Its defining feature is tissue origin from the patient, setting it apart from Nonautologous Tissue Substitute, sourced from a donor or animal, and Synthetic Substitute, made of manufactured material.
Coding & Documentation
The operative note needs to specify the material used (synthetic mesh, biologic graft, etc.), confirm that it's reinforcing or augmenting existing tissue rather than replacing it, and identify the general region involved. Coders should distinguish Supplement from a simple suture repair - if the surgeon only sutures native tissue back together with no added material, that's Repair, not Supplement.
The most common error is coding hernia repairs with mesh as Repair alone and missing the separate Supplement code for the mesh placement, or vice versa, missing that a repair was also performed alongside the mesh. Another frequent mistake is confusing Supplement with Replacement when the documentation is ambiguous about whether native tissue was removed.